leukaemia
AbbVie, Roche eye first-line use of Venclexta in leukaemia
Phil Taylor
AbbVie, leukaemia, R&D, Roche, Venclexta
0 Comment
News/ News/ Oncology/ Top stories
Cancer Research UK gives $4m funding to Glasgow Uni CML project
Piotr Wnuk
Cancer Research UK, chronic myeloid leukaemia, epigenetics, leukaemia
0 Comment
Market Access/ News/ News/ News/ News/ Oncology/ R&D/ US
FDA grants leukaemia drug ‘breakthrough’ status
Joy Persaud
acute myeloid leukaemia, Daiichi Sankyo, fda, leukaemia, Oncology, quizartinib
0 Comment
Pfizer objects to NICE methods in leukaemia drug rejection
Richard Staines
ALL, blood cancer, leukaemia, market access, NICE, Pfizer
0 Comment
Spectacular early results for Novartis’ CAR-T combined with Imbruvica
Andrew McConaghie
ASCO17, CAR T, chronic lymphocytic leukaemia, leukaemia, Novartis
0 Comment
Teva’s Trisenox approved in first line for APL
Richard Staines
Acute Promyelocytic Leukaemia, blood cancer, cancer, leukaemia, Teva
0 Comment
First ever chemotherapy-free regimen for rare leukaemia.
Gamida Cell’s cell therapy treatment gains breakthrough status
Richard Staines
Biotech, bone marrow, cancer, Gamida Cell, leukaemia
0 Comment
Regulator to expedite review of blood cancer treatment